Identification of new alpha-synuclein fibrillogenesis inhibitor using in silico structure-based virtual screening
{{output}}
Abnormal aggregation and accumulation of alpha-synuclein (αSN) in existing neurons is associated with Parkinson's disease (PD) as one of the age-related neurodegenerative disorders. Inhibition of αSN fibrillogenesis could be considered as a solution for PD d... ...
